Silence Therapeutics plc (SLN) /
The profitability of Silence Therapeutics plc over the past 4 years
Chart Silence Therapeutics plc: gross profit, operating income, net income, fiscal 2022–2025 Open the chart →Silence Therapeutics plc reported a net loss of $88.61M in fiscal 2025, the latest fiscal year on file. That year it had gross profit of $344K and an operating loss of $91.08M. It reported a loss in all 4 years shown.
Year by year
| Fiscal year | Gross profit | Operating income | Net income |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $344K | -$91.08M | -$88.61M |
| 2024ended Dec 31, 2024 | $31.45M | -$63.32M | -$45.31M |
| 2023ended Dec 31, 2023 | $18.78M | -$64.38M | -$54.23M |
| 2022ended Dec 31, 2022 | $8.19M | -$61.04M | -$50.33M |
Fiscal years as Silence Therapeutics plc reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Silence Therapeutics plc
- The revenue of Silence Therapeutics plc
- The cash flow of Silence Therapeutics plc
- The debt of Silence Therapeutics plc
- All of Silence Therapeutics plc's financials, charted
Companies of a similar size
- GRBKGreen Brick Partners, Inc.
- ASANAsana, Inc.
- CWKCushman & Wakefield Ltd.
- FBKFB FINANCIAL CORPORATION
- BTUPEABODY ENERGY CORP
Not investment advice. This page shows what Silence Therapeutics plc filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.